PL1848731T3 - Antybiotyk 107891, jego czynniki, farmaceutycznie dopuszczalne sole i kompozycje oraz ich zastosowanie - Google Patents

Antybiotyk 107891, jego czynniki, farmaceutycznie dopuszczalne sole i kompozycje oraz ich zastosowanie

Info

Publication number
PL1848731T3
PL1848731T3 PL05712250T PL05712250T PL1848731T3 PL 1848731 T3 PL1848731 T3 PL 1848731T3 PL 05712250 T PL05712250 T PL 05712250T PL 05712250 T PL05712250 T PL 05712250T PL 1848731 T3 PL1848731 T3 PL 1848731T3
Authority
PL
Poland
Prior art keywords
antibiotic
factors
compositions
pharmaceutically acceptable
acceptable salts
Prior art date
Application number
PL05712250T
Other languages
English (en)
Inventor
Ameriga Lazzarini
Luciano Gastaldo
Gianpaolo Candiani
Ismaela Ciciliato
Daniele Losi
Flavia Marinelli
Enrico Selva
Franco Parenti
Original Assignee
Sentinella Pharmaceuticals Inc Sentinella
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sentinella Pharmaceuticals Inc Sentinella filed Critical Sentinella Pharmaceuticals Inc Sentinella
Publication of PL1848731T3 publication Critical patent/PL1848731T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/001—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof by chemical synthesis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/64—Cyclic peptides containing only normal peptide links
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Biophysics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biotechnology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Epidemiology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Nutrition Science (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
PL05712250T 2005-01-26 2005-01-27 Antybiotyk 107891, jego czynniki, farmaceutycznie dopuszczalne sole i kompozycje oraz ich zastosowanie PL1848731T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US11/045,628 US7351687B2 (en) 2003-07-18 2005-01-26 Antibiotic 107891, its factors A1 and A2, pharmaceutically acceptable salts and compositions, and use thereof
PCT/US2005/002733 WO2006080920A1 (en) 2005-01-26 2005-01-27 Antibiotic 107891, its factors a1 and a2, pharmaceutically acceptable salts and compositions, and use thereof
EP05712250A EP1848731B1 (en) 2005-01-26 2005-01-27 Antibiotic 107891, its factors, pharmaceutically acceptable salts and compositions, and use thereof

Publications (1)

Publication Number Publication Date
PL1848731T3 true PL1848731T3 (pl) 2012-10-31

Family

ID=36740829

Family Applications (1)

Application Number Title Priority Date Filing Date
PL05712250T PL1848731T3 (pl) 2005-01-26 2005-01-27 Antybiotyk 107891, jego czynniki, farmaceutycznie dopuszczalne sole i kompozycje oraz ich zastosowanie

Country Status (26)

Country Link
US (1) US7351687B2 (pl)
EP (2) EP2402366A1 (pl)
JP (1) JP4191238B2 (pl)
KR (1) KR100896826B1 (pl)
CN (1) CN101189252B (pl)
AU (1) AU2005326149C1 (pl)
BR (1) BRPI0519942A2 (pl)
CA (1) CA2593801A1 (pl)
CY (1) CY1113030T1 (pl)
DK (1) DK1848731T3 (pl)
EA (1) EA016608B1 (pl)
ES (1) ES2387557T3 (pl)
HR (1) HRP20120634T1 (pl)
IL (1) IL184377A0 (pl)
MA (1) MA29237B1 (pl)
MX (1) MX2007009059A (pl)
NO (1) NO20073490L (pl)
NZ (1) NZ556368A (pl)
PL (1) PL1848731T3 (pl)
PT (1) PT1848731E (pl)
RS (1) RS52427B (pl)
SI (1) SI1848731T1 (pl)
TN (1) TNSN07286A1 (pl)
UA (1) UA87548C2 (pl)
WO (1) WO2006080920A1 (pl)
ZA (1) ZA200705495B (pl)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0600928D0 (en) 2006-01-17 2006-02-22 Novacta Biosystems Ltd Improvements relating to lantibiotics
GB0714029D0 (en) 2007-07-18 2007-08-29 Novacta Biosystems Ltd Lantibiotic-based compounds having antimicrobial activity
GB0714030D0 (en) 2007-07-18 2007-08-29 Novacta Biosystems Ltd The use of type-B lantibiotic-based compounds having antimicrobial activity
CA2749278A1 (en) 2009-01-14 2010-07-22 Novacta Biosystems Limited Deoxyactagardine derivatives
KR20110122139A (ko) 2009-02-04 2011-11-09 노박타 바이오시스템스 리미티드 액타가르딘 유도체
GB201001688D0 (en) 2010-02-02 2010-03-17 Novacta Biosystems Ltd Compounds
GB201013513D0 (en) 2010-08-11 2010-09-22 Novacta Biosystems Ltd Formulations
US11174288B2 (en) 2016-12-06 2021-11-16 Northeastern University Heparin-binding cationic peptide self-assembling peptide amphiphiles useful against drug-resistant bacteria

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS59198982A (ja) 1983-04-28 1984-11-10 Meiji Seika Kaisha Ltd 新抗生物質ｓｆ−２２４０物質およびその製造法
EP0592835A3 (en) 1992-09-23 1995-03-15 Bristol Myers Squibb Co Antibiotics of type BU-4803T.
US6551591B1 (en) 2001-09-07 2003-04-22 Essential Therapeutics, Inc. Antibiotics from microbispora
US6551581B1 (en) 2001-12-27 2003-04-22 Avon Products, Inc. Methods for improving the aesthetic appearance of skin and hair
ES2281808T3 (es) * 2003-07-18 2007-10-01 Vicuron Pharmaceuticals, Inc. Antibiotico 107891, sus factores a1 y a2, composiciones y sales farmaceuticamente aceptables y uso del mismo.
WO2006075988A1 (en) * 2005-01-12 2006-07-20 Vicuron Pharmaceuticals Inc. Antibiotic 107891, its factors a1 and a2, pharmaceutically acceptable salts and compositions, and use thereof
RS52513B (en) * 2005-01-12 2013-04-30 Sentinella Pharmaceuticals Inc. ("Sentinella") ANTIBIOTIC 107891, ITS FACTORS, PHARMACEUTICALALLY ACCEPTABLE SALTS AND MIXTURES, AND THEIR USE
UA87546C2 (ru) * 2005-01-12 2009-07-27 Найконс С.К.А.Р.Л Антибиотик 107891, его факторы а1 и а2, фармацевтически приемлемые соли, композиция и их использование

Also Published As

Publication number Publication date
EP1848731A4 (en) 2008-11-12
EP1848731A1 (en) 2007-10-31
EP2402366A1 (en) 2012-01-04
CN101189252A (zh) 2008-05-28
NZ556368A (en) 2010-09-30
AU2005326149A1 (en) 2006-08-03
HRP20120634T1 (hr) 2012-08-31
CA2593801A1 (en) 2006-08-03
UA87548C2 (ru) 2009-07-27
MX2007009059A (es) 2008-02-12
SI1848731T1 (sl) 2012-09-28
NO20073490L (no) 2007-08-07
EA200701384A1 (ru) 2008-02-28
IL184377A0 (en) 2007-10-31
CN101189252B (zh) 2012-07-18
EP1848731B1 (en) 2012-05-23
PT1848731E (pt) 2012-08-20
US20050233952A1 (en) 2005-10-20
RS52427B (en) 2013-02-28
AU2005326149B2 (en) 2009-10-29
US7351687B2 (en) 2008-04-01
EA016608B1 (ru) 2012-06-29
CY1113030T1 (el) 2016-04-13
MA29237B1 (fr) 2008-02-01
TNSN07286A1 (fr) 2008-12-31
DK1848731T3 (da) 2012-09-03
KR100896826B1 (ko) 2009-05-12
KR20070090043A (ko) 2007-09-04
AU2005326149C1 (en) 2010-04-01
ZA200705495B (en) 2008-12-31
ES2387557T3 (es) 2012-09-26
JP4191238B2 (ja) 2008-12-03
JP2008528581A (ja) 2008-07-31
BRPI0519942A2 (pt) 2009-04-07
WO2006080920A1 (en) 2006-08-03

Similar Documents

Publication Publication Date Title
IL175953A (en) Derivatives of 3-Cycloalkylaminopyrrolidine, their Pharmaceutical Salts and Preparations Containing Them
IL192298A (en) Heterocyclic Compounds, Their Acceptable Salts, Pharmaceuticals Containing and Using Them
IL184901A0 (en) 2,4-diamino-pyridopyrimidine derivatives and their use as mtor inhibitors
IL178079A (en) History of phenyl 1-phenyl-4,3,2,1-tetrahydro-beta-carboline-2-carboxylate and medicinal preparations containing them
IL189781A0 (en) Sulphonylpyrrole hydrochloride salts and pharmaceutical compositions containing the same
ZA200709856B (en) Fluorene derivatives,compositions containing said derivatives and the use thereof
EP1890677A4 (en) PHARMACEUTICAL COMPOSITIONS AND THEIR USE
AU2006321904A8 (en) 1, 1, 3-trioxo-1 , 2 , 5-thiadiazolidines and their use as PTP-ases inhibitors
ZA200705495B (en) Antibiotic 107891, its factors A1 and A2, pharmaceutically acceptable salts and compositions, and use thereof
EP1916251A4 (en) ERIANINE SALTS, PROCESSES FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME
ZA200706672B (en) 2,4-Diamino-pyridopyrimidine derivatives and their use as mTOR inhibitors
PL394604A1 (pl) Pochodna winyloazacykloalkanowa, jej zastosowanie oraz kompozycja farmaceutyczna
TWI340167B (en) Antibiotic 107891, its factors a1 and a2, pharmaceutically acceptable salts and compositions, and use thereof
IL181216A0 (en) 3, 5-seco-4-norcholestane derivatives and pharmaceutical compositions containing the same
PL1791872T3 (pl) Biotynylowane heksadekasacharydy, kompozycje farmaceutyczne i ich zastosowanie
IL186337A0 (en) Stannsoporfin compositions and administration
HK1098059A1 (en) Composition comprising itraconazole for oral administration
SI1855705T1 (sl) Antibiotik njegovi faktorji farmacevtskosprejemljive soli in sestavi in njihova uporaba
EP1865777A4 (en) STANNSOPORFIN COMPOSITIONS AND ADMINISTRATION
GB0506496D0 (en) Compound, composition and use
ZA200705494B (en) Antibiotic 107891, its factors A1 and A2, pharmaceutically acceptable salts and compositions, and use thereof
GB0519891D0 (en) Pharmaceutically acceptable salts and hydrates
IL191560A0 (en) 3,4-dihydrobenzoxazine derivatives and pharmaceutical compositions containing the same
IL195148A0 (en) 2-alkoxy-3,4,5-trihydroxy-alkylamide-benzazepines, the preparation and use thereof and compositions containing the same
GB2444005B (en) Compound, composition and use